Business
Endexx Corporation Officially Changes Name to CBD Unlimited, Inc.
Endexx Corporation Officially Changes Name to CBD Unlimited, Inc..
About this update from Endexx Corp.
[{"type":"text","content":"\nCompany to Submit FINRA Application for Corporate Name and Symbol Change\n\n \n \n \n \n \n \n \n \n \n \n \n CBD Unlimited, Inc.\n \n \n \n \n \n \n \n \n\n CAVE CREEK, AZ, Nov. 19, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Endexx Corporation (OTC PINK: EDXC), announced today that it has received approval from the Nevada Corporation Commission, completing its requested name change from Endexx Corporation to CBD Unlimited, Inc. The company will now seek approval from FINRA for a corporate name change to CBD Unlimited, Inc. and a new stock symbol. “Since 2014 we have been building our brand as one of the pioneering companies under the U.S. Farm Bill Act of 2014’s pilot program for hemp,” said Chief Executive Officer Todd Davis. “During this time, CBD Unlimited has quickly developed into a trusted brand within the hemp industry. Anticipating the Farm Bill Act of 2018, we are confident ‘The New Hemp Law’ will be conducive to the official launch of the hemp industry in the United States. The name CBD Unlimited, Inc. best reflects our company’s position and strength on behalf of the shareholders.” CBD Unlimited’s leading product suite include Maggie’s Balm, Maggie’s Mist, Mad Hatter CBD Chai Tea, Amrita, Nightcaps, Tidal Cloud, and Controlled Dose Oils and Capsules. It’s best-selling product Phyto-Bites®, a cannabidiol (CBD) infused treats for dogs that treat common physical ailments and separation anxiety, along with additional developing hemp-derived product lines have solidified CBD Unlimited’s market position. Adopting the brand name provides the company a logical transition to its trusted quality and expertise, and helps create increased relevancy to investors and shareholders. The company fully complied with the four year “Pilot Program Provision” initiated in 2014 under the US Farm Bill Act of 2014.  In the beginning, the company conducted four case studies in the clinical environment enlisting four physicians, two veteran pharmacists, and nearly 200 volunteer patients with diabetic neuropathy who eagerly tested CBD as a supportive therapy for their advanced chronic conditions. Each delivery platform was tested for four weeks. The delivery methods include vape delivery from an electronic cigarette, sublingual...